Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. LAZ
LAZ logo

LAZ Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Lazard Inc (LAZ) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
44.160
1 Day change
2.60%
52 Week Range
58.750
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Lazard Inc (LAZ) is not a strong buy at the moment for a beginner investor with a long-term focus. While there are some positive catalysts such as analyst optimism and a diversified business model, the technical indicators, financial performance, and options sentiment suggest caution. The stock's recent financial performance shows declining net income and EPS, and technical indicators do not signal a strong entry point. For a long-term investor, it may be better to wait for clearer signs of growth or a more favorable entry point.

Technical Analysis

The MACD is negative and expanding downward, indicating bearish momentum. The RSI is neutral at 21.531, and moving averages are converging, suggesting no clear trend. The stock is trading near a key support level (S1: 46.837) but remains below the pivot point (49.876), showing limited upward momentum.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high put-call volume ratio (10.49) indicates bearish sentiment in the options market. Implied volatility is elevated at 49.03, with an IV percentile of 87.2, suggesting heightened uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
2

Positive Catalysts

  • Analyst upgrades from UBS and Keefe Bruyette with price targets raised to $59 and $62, respectively. BofA initiated coverage with a Buy rating and a $65 price target, citing a diversified business model and potential cyclical tailwinds in M&A activity.

Neutral/Negative Catalysts

  • Declining financial performance in Q4 2025, with net income down -42.71% YoY and EPS down -43.75% YoY. No significant hedge fund or insider activity. Bearish technical indicators and options sentiment.

Financial Performance

In Q4 2025, revenue increased by 6.80% YoY, but net income dropped significantly by -42.71% YoY, and EPS fell by -43.75% YoY. Gross margin slightly improved to 97.48%. Overall, financial performance shows mixed results with declining profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed but leaning positive. Recent upgrades include UBS raising the price target to $59 and Keefe Bruyette to $62, with BofA initiating coverage with a Buy rating and a $65 price target. However, Morgan Stanley maintains an Underweight rating with a reduced price target of $59.

Wall Street analysts forecast LAZ stock price to rise
4 Analyst Rating
Wall Street analysts forecast LAZ stock price to rise
1 Buy
1 Hold
2 Sell
Hold
Current: 43.040
sliders
Low
46
Averages
54.5
High
59
Current: 43.040
sliders
Low
46
Averages
54.5
High
59
UBS
Michael Brown
Neutral
maintain
$54 -> $59
AI Analysis
2026-01-30
Reason
UBS
Michael Brown
Price Target
$54 -> $59
AI Analysis
2026-01-30
maintain
Neutral
Reason
UBS analyst Michael Brown raised the firm's price target on Lazard to $59 from $54 and keeps a Neutral rating on the shares.
Keefe Bruyette
Alex Bond
Outperform
maintain
$59 -> $62
2026-01-30
Reason
Keefe Bruyette
Alex Bond
Price Target
$59 -> $62
2026-01-30
maintain
Outperform
Reason
Keefe Bruyette analyst Alex Bond raised the firm's price target on Lazard to $62 from $59 and keeps an Outperform rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for LAZ
Unlock Now

People Also Watch